A multi-center 2018 study that validates the clinical performance of IsoPSA – a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen (PSA) – was presented during a special press conference at the 13th Annual Meeting of the American Urological Association (AUA) on… Continue reading More Than 40 Percent of Prostate Biopsies Could Be Avoided with a New Blood Test